順網科技(300113.SZ):已落地300+個算力雲邊緣機房
格隆匯3月1日丨順網科技(300113.SZ)在投資者互動平台表示,隨着AIGC技術發展,智能化應用將呈現爆發式增長。雖然大模型通過海量數據訓練取得了突破性進展,但相對客户也較為集中,公司主要業務方向是生成式人工智能的算力供給與應用領域,公司致力於從邊緣雲部署的消費級算力擴展到包括企業級算力與消費級算力組合的多層次算力,能夠提供更貼近客户、更具普惠性的算力服務。同時,公司自2017年以來已有佈局,已落地300+個算力雲邊緣機房,擁有多線併發能力和低時延特性。未來公司將進一步強化企業級算力的資源整合與建設, 聚焦面向客户的多層次算力解決方案,循序漸進推進順網算力業務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.